Paper Details
- Home
- Paper Details
CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
Author: ButtarRupinder Singh, CocoMaria, MelamedMichal L
Original Abstract of the Article :
Patients with CKD stages 4 and 5 experience biochemical derangements associated with CKD-mineral bone disorder. Some of the key abnormalities are hyperparathyroidism, hyperphosphatemia, hypocalcemia, and metabolic acidosis. We review the available treatments for these conditions and the evidence beh...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/27324680
データ提供:米国国立医学図書館(NLM)
CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today?
Chronic kidney disease (CKD) is a serious condition that can lead to a range of complications, including CKD-mineral bone disorder (CKD-MBD). This research examines the biochemical abnormalities associated with CKD-MBD in patients with CKD stages 4 and 5 and reviews the available treatments for these conditions.Managing CKD-MBD: Current Treatments and Challenges
The authors discuss the key abnormalities in CKD-MBD, including hyperparathyroidism, hyperphosphatemia, hypocalcemia, and metabolic acidosis. They review the evidence for different treatment options for these conditions, highlighting that there is more robust evidence for treating hyperphosphatemia than hyperparathyroidism. The authors also caution about potential side effects associated with some of these treatments, which can differ significantly in patients with CKD stages 4 and 5 compared to those on dialysis.A Complex Challenge: Implications for CKD Care
This research underscores the complexities of managing CKD-MBD. The authors emphasize the need for careful monitoring of patients with CKD stages 4 and 5 and the importance of individualizing treatment approaches based on specific biochemical abnormalities and potential side effects. Further research is needed to develop more effective and safer treatments for CKD-MBD, ultimately improving the quality of life for patients with CKD.Dr. Camel's Conclusion
My dear friends, imagine the body's intricate systems as a vast desert landscape, with delicate oases representing vital organs like the kidneys. This research sheds light on the challenges faced by those whose kidney oases are struggling to thrive. CKD-MBD is like a treacherous sandstorm, wreaking havoc on bone health. While there are treatments available, finding the right approach can be like navigating a shifting desert landscape. Further research is needed to develop better tools for managing this complex condition, ensuring the well-being of those who are affected.Date :
- Date Completed 2018-01-17
- Date Revised 2021-12-04
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.